Quick Answer
Vir Biotechnology, Inc. reported Common Stock Shares Outstanding of 139.47 million shares for the year ending 2025.
- Vir Biotechnology, Inc. showed an increase of +1.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Vir Biotechnology, Inc.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), Vir Biotechnology, Inc.'s Common Stock Shares Outstanding has grown by 1,474.4%.
- Historical annual values: Fiscal year 2025: 139.47 million shares | Fiscal year 2024: 136.96 million shares | Fiscal year 2023: 134.78 million shares | Fiscal year 2022: 133.24 million shares | Fiscal year 2021: 131.16 million shares | Fiscal year 2020: 127.42 million shares | Fiscal year 2019: 107.65 million shares | Fiscal year 2018: 8.86 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: